Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 6

Results: 8

Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 615, doi. 10.1007/s40273-024-01381-z

By:

Sugden, Bradley M.;
Grimm, Sabine E.;
Wolff, Robert;
Armstrong, Nigel;
Otten, Thomas;
Abu-Zahra, Teebah;
Perry, Mark;
Patel, Mubarak;
Chen, Jiongyu;
Noake, Caro;
Joore, Manuela;
Witlox, Willem J. A.

Publication type:

Article

Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 633, doi. 10.1007/s40273-024-01375-x

By:

Veijer, Clazinus;
van Hulst, Marinus H.;
Friedrichson, Benjamin;
Postma, Maarten J.;
van Asselt, Antoinette D.I.

Publication type:

Article

Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 679, doi. 10.1007/s40273-024-01371-1

By:

Kenseth, Anna;
Kantorova, Dominika;
Seo, Mikyung Kelly;
Aas, Eline;
Cairns, John;
Kerr, David;
Askautrud, Hanne;
Jacobsen, Jørn Evert

Publication type:

Article

Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 693, doi. 10.1007/s40273-024-01385-9

By:

Herring, William L.;
Gallagher, Meghan E.;
Shah, Nirmish;
Morse, KC;
Mladsi, Deirdre;
Dong, Olivia M.;
Chawla, Anjulika;
Leiding, Jennifer W.;
Zhang, Lixin;
Paramore, Clark;
Andemariam, Biree

Publication type:

Article

Market Transparency in Medicine Pricing: Pathways to Fair Pricing.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 611, doi. 10.1007/s40273-024-01390-y

By:

Carapinha, João L.

Publication type:

Article

Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 619, doi. 10.1007/s40273-024-01370-2

By:

Grand, Tobias Sydendal;
Ren, Shijie;
Hall, James;
Åström, Daniel Oudin;
Regnier, Stephane;
Thokala, Praveen

Publication type:

Article

Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case Study.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 663, doi. 10.1007/s40273-024-01366-y

By:

Khan, Zareen Abbas;
Kidholm, Kristian;
Pedersen, Sindre Andre;
Haga, Silje Marie;
Drozd, Filip;
Sundrehagen, Thea;
Olavesen, Ellen;
Halsteinli, Vidar

Publication type:

Article

Childhood Transitions Between Weight Status Categories: Evidence from the UK Millennium Cohort Study.

Published in:

PharmacoEconomics, 2024, v. 42, n. 6, p. 649, doi. 10.1007/s40273-024-01361-3

By:

Onyimadu, Olu;
Astbury, Nerys M.;
Achana, Felix;
Petrou, Stavros;
Violato, Mara

Publication type:

Article